MDS Virtual Congress 2021 Archives - Page 32 of 132

CVT-301 (levodopa inhalation powder) improves Patient Global Impression of Change (PGIC) over 1 year in patients with Parkinson’s disease (PD): a meta-analysis

M. Saint-Hilaire, A. Corbin, P. Zhao, D. Kegler-Ebo (Boston, USA)
CVT-301 (levodopa inhalation powder): meta-analysis of safety in patients with Parkinson’s disease (PD)

P. Lewitt, P. Zhao, A. Corbin, D. Kegler-Ebo, B. Blank (West Bloomfield, USA)
D-penicillamine induced lupus erythematosus – the complication of Wilson’s disease treatment – a case report.

A. Antos, T. Litwin, A. Przybyłkowski, M. Skowrońska, I. Kurkowska-Jastrzębska, A. Członkowska (Warsaw, Poland)
Daily fluctuations of plasma ghrelin level in patients with different motor subtypes of Parkinson`s disease

K. Tarianyk, A. Shkodina (Poltava, Ukraine)
Dance for Movement Disorders: Improving Health and Quality of Life

K. Mason, D. Leventhal, J. Sonke, J. Langley, B. Whiteside, T. Gyang, B. Borgert, E. Johnson, D. Riley, C. Cassidy, L. Sinclair (Gainesville, USA)
Dance training and performance in patients with Parkinson disease: effects on motor functions and patients’ well-being.

O. Bouquiaux, A. Thibaut, C. Beaudart, G. Dorban (Fraiture-En-Condroz, Belgium)
DAT-IQ improves power to detect longitudinal change in DaT deficit in SURE-PD3

Z. Fan, J. Seibyl, K. Marek, M. Schwarzschild, E. Macklin, R. Gunn (London, United Kingdom)
DAT-SPECT in old onset Parkinson’s disease: should we trust?

G. Palermo, S. Giannoni, D. Frosini, U. Bonuccelli, R. Ceravolo (Pisa, Italy)
Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium

M. Muller, D. Dexter, J. Cosman, C. Zadikoff, S. Ali, N. Barwick, B. Bloem, B. Boroojerdi, J. Burton, C. Carroll, J. Cedarbaum, T. Dam, P. Dawkins, D. Grosset, N. Hanan, D. Hill, M. Hu, D. Jennings, S. Jones, K. Kieburtz, R. Lawson, K. Lee, K. Marek, H. Matthews, N. Mehrotra, J. Molinuevo, P. Muglia, A. Naito, G. Pagano, S. Sardi, M. Schwarzschild, A. Simen, T. Simuni, G. Stebbins, C. Venuto, C. Williams-Gray, D. Stephenson (Tucson, USA)
Data-driven model of dynamic biomarkers in SCA3 – from early pre-ataxic to late ataxic disease stages

J. Faber, T. Schaprian, C. Wilke, J. Huebener-Schmid, O. Riess, H. Garcia-Moreno, P. Giunti, B. Vande Warrenburg, J. van Gaalen, M. Lima, M. Raposo, L. Pereira, M. Santana, L. Schoels, J. de Vries, J. Infante, H. Jacobi, D. Timmann-Braun, K. Reetz, M. Schmid, T. Klockgether (Bonn, Germany)